Are Pharmaceutical Companies Prioritizing Multi-Indication Drugs?

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Prioritizing pharmaceutical activities: a simulation exercise.

Hospital pharmacy practice has undergone many changes over the past 3 decades. New technologies, such as automated repackaging, robotic unit-dose cart-fill systems, and automated dispensing cabinets, have improved the efficiency, effectiveness, and quality of drug distribution systems. In addition, new pharmacy practice models have been introduced in which pharmacists accept responsibility and ...

متن کامل

Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern

healthcare and Ranbaxy have been bought by Abbott and Daiichi Sankyo, respectively.[3] Cipla, an indigenous company, lone with a market share of about 5.4% tops the list of top 10 companies in India. The increasing presence of foreign companies among the top pharmaceutical companies in India is may be due to a few buyouts which happened in the recent past. Daiichi Sankyo, a leading Japanese pha...

متن کامل

Virtual pharmaceutical companies: collaborating flexibly in pharmaceutical development.

Research and development (R&D) collaborations represent one approach chosen by the pharmaceutical industry to tackle current challenges posed by declining internal R&D success rates and fading of the blockbuster model. In recent years, a flexible concept to collaborate in R&D has emerged: virtual pharmaceutical companies (VPCs). These differ from other R&D companies, such as biotech start-ups, ...

متن کامل

Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies

OBJECTIVES To define a series of clinical trial transparency measures and apply them to large pharmaceutical and biotechnology companies and their 2014 FDA-approved drugs. DESIGN Cross-sectional descriptive analysis of all clinical trials supporting 2014 Food and Drugs Administration (FDA)-approved new drug applications (NDAs) for novel drugs sponsored by large companies. DATA SOURCES Data ...

متن کامل

Interaction between pharmaceutical companies and physicians who prescribe antiretroviral drugs for treating AIDS.

CONTEXT AND OBJECTIVE Given that Brazil has a universal public policy for supplying medications to treat HIV and AIDS, the aim here was to describe the forms of relationship between physicians and the pharmaceutical companies that produce antiretrovirals (ARVs). DESIGN AND SETTING Cross-sectional epidemiological study conducted in the state of São Paulo. METHODS Secondary database linkage w...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Value in Health

سال: 2017

ISSN: 1098-3015

DOI: 10.1016/j.jval.2017.08.2762